Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03710161 · ClinicalTrials.gov registry record · Phase 4
Effect of Vitamin D Supplementation on Balance in CKD
A Phase 4 study, sponsored by University of Nebraska.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT03710161 is a Phase 4 study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 5 participants.
The verdict
NCT03710161, a Phase 4 study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
Patients with end-stage renal disease on dialysis (ESRD5D) are 4-5x more likely to suffer from a fracture. Fractures can occur spontaneously but typically occur after a fall. Further, 70-90% of patients with ESRD5D are vitamin D deficient. Vitamin D supplementation has become routine care for many in this patient population, but evidence is lacking to support this practice. The proposed projects objective is to gather needed preliminary data regarding the effects of vitamin D supplementation on balance and muscle strength in patients with ESRD5D.
Interventions
- DRUG Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-07-08 |
| Est. Completion | 2020-03-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03710161
The ClinicalTrials.gov registry entry for NCT03710161 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D is the first listed.
NCT03710161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03710161 about?
NCT03710161 is a clinical study titled "Effect of Vitamin D Supplementation on Balance in CKD". Patients with end-stage renal disease on dialysis (ESRD5D) are 4-5x more likely to suffer from a fracture. Fractures can occur spontaneously but typically occur after a fall. Further, 70-90% of patients with ESRD5D are vitamin D deficient. Vitamin D supplementation has become routine care for many i...
What is the current status of trial NCT03710161?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2019-07-08. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT03710161?
The interventions under investigation include: Vitamin D (DRUG).
Who is sponsoring clinical trial NCT03710161?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.